Interview with Dr. Matthew Horton, Pathologist, Part 2: Neuroendocrine Lung Tumors & Bronchioloalveolar Carcinoma

Article and Video CATEGORIES

Cancer Journey

ABOUT

Howard Jack West, MD, Founder, Board President

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

Interview with Dr. Matthew Horton, Pathologist, Part 2: Neuroendocrine Lung Tumors & Bronchioloalveolar Carcinoma

Dr West

Thu, 01/28/2010 - 20:53

Author

Howard (Jack) West, MD

This is a continuation of my discussion with Dr. Matthew Horton, a pathologist with a special training and a great expertise in lung pathology who works here in Seattle at a company called CellNetix.

This portion of our discussion covers the spectrum of neuroendocrine lung tumors, ranging from carcinoids to small cell lung cancer and large cell neuroendocrine carcinomas; we then turn to a discussion of bronchioloalveolar carcinoma (BAC), including everything from a little history to a look forward at a new interpretation of BAC. Below you'll find the audio and video versions of our discussion (the video with a few images of what we're talking about), and the associated transcript and figures.

[powerpress]

Dr-horton-pt-2-neuroendo-lung-tumors-and-bac-audio-podcast

Dr-horton-pt-2-neuroendo-lung-tumors-and-bac-transcript

Dr-horton-pt-2-neuroendo-lung-tumors-and-bac-figures

We'll conclude the discussion with Dr. Horton in a final podcast from my interview with him.

Next Previous link

Previous Post Next Post

Related Content

Advance Directives

Article

Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated.

Applications are now closed!... Be a Part of the Patient Perspectives: Clinical Trials Storytelling Program - 2024-25

Article

Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!